Global Hepatitis Test Solution and Diagnosis Market: Industry Analysis & Forecast (2020-2026) – By Disease Type, Technology, End-User and Region.

Global Hepatitis Test Solution and Diagnosis Market is expected to account for USD 5.37 billion by 2027 and expanding at a CAGR of nearly 5.2 % in the forecast period of 2019 to 2027. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.

Global Hepatitis Test Solution and Diagnosis Market Dynamics

Global Hepatitis Health Sector on Viral Hepatitis is stated that 30% of the persons living with HBV and HCV by 2020 and it is expected to reach 90% by 2030. These improve the clinical outcomes and save lives, as well as reducing hepatitis transmission and new infections. The development of highly effective, well-tolerated oral direct-acting antiviral (DAA) treatment regimens with high rates of cure after 8–12 weeks of treatment has to make revolutions in hepatitis test solutions and diagnostics. Available resources for effective long-term antiviral treatment with tenofovir or entecavir are the major driver for the global market. The high increase in global burden regarding the diagnostic treatments for the hepatitis disease and the advances and opportunities for treatment led to give the growth opportunities for the global market. Cost-effective diagnostic tests and evidence-based evolutions in the performance of the diagnostic tests as well as testing strategies make the treatments available for the patients and helps to increase the awareness of the tests among them. Evidence-based ongoing studies on the hepatitis virus from countries from Asia, North America, and Western Europe and the availability of a large amount of data for further studies create the roadmap for further hepatitis testing. The high prices of these new medicines remain a major barrier to access growth of the global market in many countries.

Global Hepatitis Test Solution and Diagnosis Market Segment Analysis:

The report groups the Global Hepatitis Test Solution and Diagnosis Market in different segments By Disease Type, Technology, End-User and Region to forecast the revenues and analyze the market share of each segment over the forecast period. Global Hepatitis Test Solution and Diagnosis Market To know about the Research Methodology :- Request Free Sample Report Based on Disease Type, the Global Hepatitis Test Solution and Diagnosis Market is segmented into Hepatitis B, HCV, HAV, HDV. The Hepatitis B segment was dominant in 2019 and is expected to command a market share of xx% by 2026. Hepatitis B virus (HBV) infection is a major cause of acute and chronic liver disease globally and it causes an estimated 1.4 million deaths annually. Till today, 248 million people are suffering from chronic HBV infection, and that 110 million persons are HBV-antibody positive. Chronic HBV is a disproportionately major burden for the population mainly from low- and middle-income countries (LMICs), particularly in Asia and Africa. Additionally, even in low-prevalence areas, certain populations have high levels of HCV infection, these factors driving the global hepatitis test and diagnosis market in the globe. PCR Segment was dominant in 2019 and is expected to command a market share of xx% by 2026. At present, polymerase chain reaction (PCR) is the dominant way that global healthcare systems are testing citizens for hepatitis. At the moment the majority of the current hepatitis tests that all the reports are coming from are using PCR. It is the largest conducting test across the global laboratories to detect the hepatitis antigen present in the human body. The convenient home-based hepatitis PCR test has a high demand for early detection of the same. Because hepatitis exhibits a range of clinical manifestations, from mild flu-like symptoms to life-threatening conditions, it is important to have efficient RT-PCR testing during the early stages of infection to identify hepatitis patients from those with other illnesses. This avoids unnecessary deaths of individuals and the spread of infection by positive individuals.

Global Hepatitis Test Solution and Diagnosis Market Regional Analysis:

Hepatitis Test Solution and Diagnosis Market Asia Pacific is expected to command the largest market share of XX% by 2026. Developed healthcare facilities in the Asia Pacific countries like the Malaysia, India, China and the large populations suffering from hepatitis are driven by the global market. Evolutions in the laboratory testing facilities and improvements in the hepatitis diagnostic testing facilities help to improve the testing facilities and save the lives of the individuals. Currently, vast access to diagnostics tests, antiviral therapies, and appropriate laboratory infrastructure are impelling the global market in the Asia Pacific region. In the Asia Pacific, there is a huge scope for opportunities to improve the identification and treatment of persons with chronic hepatitis B and C. Approximately 60% of the world’s population live in areas where HBV infection is highly endemic, particularly in Asia and Africa. Peoples from the Asia Pacific Countries most peoples are infected with HBV and/or HCV remain unaware of their infection. Many countries of Asia Pacific are equipped with low-income countries where many of the peoples are infected with Hepatitis and the infection spreads easily which in these regions are likely drives the global market in this region. The objective of the report is to present a comprehensive analysis of the Global Hepatitis Test Solution and Diagnosis Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Hepatitis Test Solution and Diagnosis Market dynamics, structure by analyzing the market segments and projects the Global Hepatitis Test Solution and Diagnosis Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Hepatitis Test Solution and Diagnosis Market make the report investor’s guide.

Global Hepatitis Test Solution and Diagnosis Market Report Scope: Inquire before buying

Global Hepatitis Test Solution and Diagnosis Market
Report Coverage Details
Base Year: 2020 Forecast Period: 2021-2027
Historical Data: 2016 to 2020 Market Size in 2020: US $ 3.77 Bn.
Forecast Period 2021 to 2027 CAGR: 5.2% Market Size in 2027: US $ 5.37 Bn.
Segments Covered: by Disease Type • Hepatitis B • HCV • HAV • HDV
by Technology • ELISA • RDT • PCR • Transcription Mediated Amplification
by End-User • Hospitals • Diagnostic Laboratories • Blood Banks

Global Hepatitis Test Solution and Diagnosis Market Key Players

• F. Hoffmann-La Roche Ltd • Abbott Laboratories • Bio-Rad • Siemens • DiaSorin • QIAGEN • Danaher • bioMérieux • Grifols • Ortho Clinical Diagnostics • FUJIREBIO Inc. • Avantor Inc. • Quest Diagnostics Incorporated • MedMira Inc. • Laboratory Corporation of America Holdings • Cigna • OraSure Technologies Inc.
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Hepatitis Test Solution and Diagnosis Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Hepatitis Test Solution and Diagnosis Market 3.4. Geographical Snapshot of the Hepatitis Test Solution and Diagnosis Market, By Manufacturer share 4. Global Hepatitis Test Solution and Diagnosis Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Hepatitis Test Solution and Diagnosis Market 5. Supply Side and Demand Side Indicators 6. Global Hepatitis Test Solution and Diagnosis Market Analysis and Forecast, 2019-2026 6.1. Global Hepatitis Test Solution and Diagnosis Market Size & Y-o-Y Growth Analysis. 7. Global Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 7.1.1. Hepatitis B 7.1.2. HCV 7.1.3. HAV 7.1.4. HDV 7.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 7.2.1. ELISA 7.2.2. RDT 7.2.3. PCR 7.2.4. Transcription Mediated Amplification 7.3. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 7.3.1. Hospitals 7.3.2. Diagnostic Laboratories 7.3.3. Blood Banks 7.3.4. Nursing Homes 8. Global Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 9.1.1. Hepatitis B 9.1.2. HCV 9.1.3. HAV 9.1.4. HDV 9.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 9.2.1. ELISA 9.2.2. RDT 9.2.3. PCR 9.2.4. Transcription Mediated Amplification 9.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 9.3.1. Hospitals 9.3.2. Diagnostic Laboratories 9.3.3. Blood Banks 9.3.4. Nursing Homes 10. North America Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 12. Canada Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 13. Mexico Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 14. Europe Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 15. Europe Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 17. France Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 18. Germany Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 19. Italy Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 20. Spain Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 21. Sweden Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 22. CIS Countries Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 23. Rest of Europe Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 24. Asia Pacific Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 25. Asia Pacific Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 27. India Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 28. Japan Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 29. South Korea Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 30. Australia Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 31. ASEAN Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 32. Rest of Asia Pacific Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 33. Middle East Africa Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 34. Middle East Africa Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 36. GCC Countries Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 37. Egypt Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 38. Nigeria Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 39. Rest of ME&A Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 40. South America Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 41. South America Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 43. Argentina Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 44. Rest of South America Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Disease Type, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Hepatitis Test Solution and Diagnosis Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. F. Hoffmann-La Roche Ltd 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Abbott Laboratories 45.3.3. Bio-Rad 45.3.4. Siemens 45.3.5. DiaSorin 45.3.6. QIAGEN 45.3.7. Danaher 45.3.8. bioMérieux 45.3.9. Grifols 45.3.10. Ortho Clinical Diagnostics 45.3.11. FUJIREBIO Inc. 45.3.12. Avantor Inc. 45.3.13. Quest Diagnostics Incorporated 45.3.14. MedMira Inc. 45.3.15. Laboratory Corporation of America Holdings 45.3.16. Cigna 45.3.17. OraSure Technologies Inc. 46. Primary Key Insights

About This Report

Report ID 102719
Category Healthcare
Published Date May 2021
Updated Date
Contact Us